Several studies have indicated a role of innate and adaptive immunity in HCC progression and control [2,3,5], e.g., a longer progression-free survival has been associated with increased frequencies of CD8+ T cells targeting tumor-associated antigens [6], and of natural killer cells (NK cells) [7,8]. The gene discussed is CD8A; the disease is neoplasm.